CURRENT ISSUES IN THE PHARMACOLOGIC MANAGEMENT OF ALLERGIC RHINITIS AND ASTHMA

A. Togias

Abstract:We currently advocate the concept that noninfectious rhinitis and asthma should be regarded as one syndrome with manifestations in both the nasal and the lower airways. Therefore, management of these conditions should consider targeting both sites of the respiratory tract. Although the pathophysiology of allergic rhinitis and asthma is almost identical when the immunologic and inflammatory aspects are considered, tissue differences render some of the humoral mediators of the allergic reaction more important in one or the other part of the respiratory tract. In accordance to this concept, antihistamines are more effective in rhinitis and have little, if any, effect in asthma, whereas leukotriene receptor antagonists seem to have stronger effects in asthma. Also, betaadrenergic agonists, which act as smooth muscle relaxants, have only a role in asthma, whereas alpha agonists, which act as vasoconstrictors, only in rhinitis. In this brief review article, we summarize current management strategies in rhinitis and asthma viewed as one condition. In discussing these strategies, we will refer to a number of presentations and discussions that took place at the 2003 meeting of the World Allergy Organization in Vancouver, Canada that were selected for coverage in this Advanced Studies in Medicine issue.